Framingham, Massachusetts-based Alzheon was awarded a $47 million grant over five years from the U.S. National Institute on Aging (NIA), part of the National Institutes of Health, to assist with a Phase III clinical trial of ALZ-801.
Little headway has been made in developing a treatment for Alzheimer’s disease, but that could be changing.
People who try to avoid junk food may lose similar amounts of weight on a low-carb or low-fat diet even when their genetics suggest that one of these options should be better for them.